Ashvattha Therapeutics, Inc. Clinical Trial Pipeline: 3 Active Trials, 3 Changes This Month

3

Active Trials

2

Recruiting

4

Disease Areas

3

Changes, 30 Days

What Changed in the Last 30 Days

Detected	Trial	Change
2026-07-19	NCT07370155 Study Evaluating Safety & Tolerability of Migaldendranib in Healthy Volunteers	Recruitment opened
2026-07-19	NCT07370155 Study Evaluating Safety & Tolerability of Migaldendranib in Healthy Volunteers	date change Primary completion pushed: 2026-05-13 -> 2026-08-13
2026-07-19	NCT07370155 Study Evaluating Safety & Tolerability of Migaldendranib in Healthy Volunteers	date change Completion pushed: 2026-06-10 -> 2026-10-10

Active Trials by Phase

Phase 2

1

Phase 1/2

1

Phase 1

1

Active Trials

NCT ID	Title	Condition	Status
Phase 2
NCT05387837	Safety, Tolerability and PK of Subcutaneous D-4517.2 in Subjects With Wet AMD or DME	Neovascular Age-related Macular Degeneration	Active, Not Recruiting
Phase 1/2
NCT05395624	Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy…	Amyotrophic Lateral Sclerosis (ALS)	Recruiting
Phase 1
NCT07370155	Study Evaluating Safety & Tolerability of Migaldendranib in Healthy Volunteers	Healthy Volunteers	Recruiting

Disease Areas

Get alerts when Ashvattha Therapeutics, Inc.'s trials change

Status changes, date slips, and new filings — detected daily, delivered to your inbox.